Unknown PHASE1 INTERVENTIONAL 4-arm NCT03469089

Touchscreen-based Cognitive Tests in Healthy Volunteers

Touchscreen-based Cognitive Tests in Assessment of Ketamine-induced Cognitive Deficits in Healthy Volunteers

Sponsor: University of Eastern Finland

Conditions Cognitive Symptom Schizophrenia

Interventions Ketamine 0.31 Ketamine 0.58 Modafinil Placebo for ketamine Placebo for modafinil

Updated 7 times since 2018 Last updated: Oct 15, 2018 Started: Mar 12, 2018 Primary completion: May 16, 2018 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cognitive Symptom and Schizophrenia and is currently ongoing. University of Eastern Finland leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Nov 2020 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status
Nov 2018 — Nov 2020 [monthly]

Active Not Recruiting PHASE1

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Eastern Finland

Data source: University of Eastern Finland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuopio, Finland